Amarin Announces Market Introduction of Vascepa(R) (icosapent ethyl) Capsules for the Treatment of Very High Triglycerides (VHTG)

[at noodls] – -First and Only FDA Approved Pure-EPA Omega-3 Prescription Therapy Now Available- -Vascepa Reduces VHTG Without Raising LDL Cholesterol- BEDMINSTER, N.J., and DUBLIN, Ireland, Jan. 24, 2013 (GLOBE NEWSWIRE) … more

View todays social media effects on AMRN

View the latest stocks trending across Twitter. Click to view dashboard

See who Amarin is hiring next, click here to view